Procaps Group (Procaps Group) FCF Yield % : 11.61 (As of Jun. 19, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Procaps Group FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Procaps Group's Trailing 12-Month Free Cash Flow is $34.1 Mil, and Market Cap is $293.3 Mil. Therefore, Procaps Group's FCF Yield % for today is 11.61%.

The historical rank and industry rank for Procaps Group's FCF Yield % or its related term are showing as below:

PROC' s FCF Yield % Range Over the Past 10 Years
Min: -5.01 Med: 1 Max: 15.05
Current: 11.61

During the past 4 years, the highest FCF Yield % of Procaps Group was 15.05%. The lowest was -5.01%. And the median was 1.00%.

PROC's FCF Yield % is ranked better than
92.04% of 1080 companies
in the Drug Manufacturers industry
Industry Median: -0.145 vs PROC: 11.61

Procaps Group's FCF Margin % for the quarter that ended in Sep. 2023 was 33.54%.

Procaps Group FCF Yield % Historical Data

The historical data trend for Procaps Group's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procaps Group FCF Yield % Chart

Procaps Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

FCF Yield %

1.16

-2.95

Procaps Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Yield %	Get a 7-Day Free Trial											-0.85	-11.12	-1.38	10.37	38.89

Competitive Comparison of Procaps Group's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Procaps Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Procaps Group's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procaps Group's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Procaps Group's FCF Yield % falls into.

Procaps Group FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Procaps Group's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-17.469	/	592.326
	=	-2.95%

Procaps Group's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	39.714	*	4	/	408.42288
	=	38.89%

Procaps Group FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Procaps Group FCF Yield % Related Terms

Thank you for viewing the detailed overview of Procaps Group's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Procaps Group (Procaps Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procaps Group SA (NAS:PROC) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

9X1:Germany

Address

9 Rue de Bitbourg, Luxembourg, LUX, L-1273

Website

https://www.procapsgroup.com

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Executives

Alexandre Weinstein Manieu	director, 10 percent owner	CHASHAM PLACE, FLAT 1, LONDON X0 SW1X 8HG
Ruben Minski	director, 10 percent owner, officer: Chief Executive Officer	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Jose Minski	director, 10 percent owner	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Sognatore Trust	10 percent owner	OFICINA 503A-02, EDIFICIO QUANTUM, (500) RUTA 8 KM. 17.500 ZONAMERICA, MONTEVIDEO X3 91600
Simphony Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Deseja Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Hoche Partners Pharma Holding S.a.	10 percent owner	3A VAL SAINTE CROIX, LUXEMBOURG N4 L-1371